BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 17566084)

  • 21. Heparin affin regulatory peptide binds to vascular endothelial growth factor (VEGF) and inhibits VEGF-induced angiogenesis.
    Héroult M; Bernard-Pierrot I; Delbé J; Hamma-Kourbali Y; Katsoris P; Barritault D; Papadimitriou E; Plouet J; Courty J
    Oncogene; 2004 Mar; 23(9):1745-53. PubMed ID: 15001987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Heterogeneity of capillary endothelial cells for basic fibroblast growth factor-induced paracrine signaling.
    Lee TH; Lee HC; Son YS; Kang MA; Park MJ; Nam MJ; Lee SH; Hong SI
    Endothelium; 2006; 13(3):191-203. PubMed ID: 16840175
    [TBL] [Abstract][Full Text] [Related]  

  • 23. VEGF189 stimulates endothelial cells proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA.
    Hervé MA; Buteau-Lozano H; Mourah S; Calvo F; Perrot-Applanat M
    Exp Cell Res; 2005 Sep; 309(1):24-31. PubMed ID: 15996656
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The transforming growth factor-beta family members bone morphogenetic protein-2 and macrophage inhibitory cytokine-1 as mediators of the antiangiogenic activity of N-(4-hydroxyphenyl)retinamide.
    Ferrari N; Pfeffer U; Dell'Eva R; Ambrosini C; Noonan DM; Albini A
    Clin Cancer Res; 2005 Jun; 11(12):4610-9. PubMed ID: 15958647
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The vasostatin-1 fragment of chromogranin A preserves a quiescent phenotype in hypoxia-driven endothelial cells and regulates tumor neovascularization.
    Veschini L; Crippa L; Dondossola E; Doglioni C; Corti A; Ferrero E
    FASEB J; 2011 Nov; 25(11):3906-14. PubMed ID: 21825034
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tumor necrosis factor and vascular endothelial growth factor induce endothelial integrin repertories, regulating endovascular differentiation and apoptosis in a human extravillous trophoblast cell line.
    Fukushima K; Miyamoto S; Tsukimori K; Kobayashi H; Seki H; Takeda S; Kensuke E; Ohtani K; Shibuya M; Nakano H
    Biol Reprod; 2005 Jul; 73(1):172-9. PubMed ID: 15788755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The vascular targeting property of paclitaxel is enhanced by SU6668, a receptor tyrosine kinase inhibitor, causing apoptosis of endothelial cells and inhibition of angiogenesis.
    Naumova E; Ubezio P; Garofalo A; Borsotti P; Cassis L; Riccardi E; Scanziani E; Eccles SA; Bani MR; Giavazzi R
    Clin Cancer Res; 2006 Mar; 12(6):1839-49. PubMed ID: 16551869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum derived from multiple trauma patients promotes the differentiation of endothelial progenitor cells in vitro: possible role of transforming growth factor-beta1 and vascular endothelial growth factor165.
    Henrich D; Hahn P; Wahl M; Wilhelm K; Dernbach E; Dimmeler S; Marzi I
    Shock; 2004 Jan; 21(1):13-6. PubMed ID: 14676678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tum-1, a tumstatin fragment, gene delivery into hepatocellular carcinoma suppresses tumor growth through inhibiting angiogenesis.
    Goto T; Ishikawa H; Matsumoto K; Nishimura D; Kusaba M; Taura N; Shibata H; Miyaaki H; Ichikawa T; Hamasaki K; Nakao K; Maeshima Y; Eguchi K
    Int J Oncol; 2008 Jul; 33(1):33-40. PubMed ID: 18575748
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel vasculo-angiogenic effect of cilostazol mediated by cross-talk between multiple signalling pathways including the ERK/p38 MAPK signalling transduction cascade.
    Chao TH; Tseng SY; Li YH; Liu PY; Cho CL; Shi GY; Wu HL; Chen JH
    Clin Sci (Lond); 2012 Aug; 123(3):147-59. PubMed ID: 22339730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effective angiostatic treatment in a murine metastatic and orthotopic hepatoma model.
    Raskopf E; Dzienisowicz C; Hilbert T; Rabe C; Leifeld L; Wernert N; Sauerbruch T; Prieto J; Qian C; Caselmann WH; Schmitz V
    Hepatology; 2005 Jun; 41(6):1233-40. PubMed ID: 15915456
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiangiogenic activity of beta-eudesmol in vitro and in vivo.
    Tsuneki H; Ma EL; Kobayashi S; Sekizaki N; Maekawa K; Sasaoka T; Wang MW; Kimura I
    Eur J Pharmacol; 2005 Apr; 512(2-3):105-15. PubMed ID: 15840394
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting tumor angiogenesis with histone deacetylase inhibitors: the hydroxamic acid derivative LBH589.
    Qian DZ; Kato Y; Shabbeer S; Wei Y; Verheul HM; Salumbides B; Sanni T; Atadja P; Pili R
    Clin Cancer Res; 2006 Jan; 12(2):634-42. PubMed ID: 16428510
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro angiogenic effects of pancreatic bile salt-dependent lipase.
    Rebaï O; Le Petit-Thevenin J; Bruneau N; Lombardo D; Vérine A
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):359-64. PubMed ID: 15569825
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The inhibitory effects of endostatin on endothelial cells are modulated by extracellular matrix.
    Delaney CE; Weagant BT; Addison CL
    Exp Cell Res; 2006 Aug; 312(13):2476-89. PubMed ID: 16725139
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p38 MAP kinase activation by vascular endothelial growth factor mediates actin reorganization and cell migration in human endothelial cells.
    Rousseau S; Houle F; Landry J; Huot J
    Oncogene; 1997 Oct; 15(18):2169-77. PubMed ID: 9393975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vasostatin-2 inhibits cell proliferation and adhesion in vascular smooth muscle cells, which are associated with the progression of atherosclerosis.
    Hou J; Xue X; Li J
    Biochem Biophys Res Commun; 2016 Jan; 469(4):948-53. PubMed ID: 26721428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vasostatin inhibits VEGF-induced endothelial cell proliferation, tube formation and induces cell apoptosis under oxygen deprivation.
    Shu Q; Li W; Li H; Sun G
    Int J Mol Sci; 2014 Apr; 15(4):6019-30. PubMed ID: 24722573
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromogranin A and its fragments as regulators of small intestinal neuroendocrine neoplasm proliferation.
    Giovinazzo F; Schimmack S; Svejda B; Alaimo D; Pfragner R; Modlin I; Kidd M
    PLoS One; 2013; 8(11):e81111. PubMed ID: 24260544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromogranin A and the endothelial barrier function.
    Corti A; Ferrero E
    Curr Med Chem; 2012; 19(24):4051-8. PubMed ID: 22834794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.